Cara Beach, DPM
Podiatrist · Portland, ORNPI 1619338829
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,823 of the $4,416 with a category attached, or 63.9%. 29 manufacturers reported payments, led by Steelhead Surgical Inc at 36.5% of the total. Reporting peaked in 2022 at $2,149 and has fallen 90.3% since, to $209 in 2025.
Across 84 payments — averaging $52.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$2K
- Stryker$573
- Johnson & Johnson$489
- Smith+Nephew$387
- Treace Medical Concepts, Inc.$187
- Zimmer Biomet$140
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,82364%
- Education$1,59336%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 3 | $1,612 |
| Stryker | 12 | $573 |
| Johnson & Johnson | 9 | $489 |
| Smith+Nephew | 16 | $387 |
| Treace Medical Concepts, Inc. | 4 | $187 |
| Zimmer Biomet | 3 | $140 |
| Arteriocyte Medical Systems, Inc. | 2 | $138 |
| Organogenesis Inc. | 2 | $128 |
| Medartis Inc. | 1 | $78 |
| Nevro Corp. | 4 | $67 |
| IBSA Pharma Inc. | 3 | $66 |
| Encore Medical, LP | 1 | $52 |
| GRT US Holding, Inc. | 3 | $46 |
| Bioventus LLC | 2 | $43 |
| Heron Therapeutics, Inc. | 2 | $35 |
| Tactile Systems Technology Inc | 1 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
| Avita Medical Americas, LLC | 1 | $34 |
| DJO, LLC | 1 | $33 |
| Paragon 28, Inc. | 1 | $32 |
| Linvatec Corporation | 1 | $30 |
| KCI USA, Inc. | 2 | $30 |
| Orthofix Medical, Inc. | 2 | $28 |
| Medtronic | 1 | $27 |
| Axogen | 1 | $24 |
| Next Science LLC | 1 | $20 |
| Averitas Pharma Inc. | 1 | $19 |
| Mimedx Group, Inc. | 1 | $16 |
| Medline Industries LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HAMMERLOCK$144
- PuraPly$114
- Stratum Foot Plating System$112
- PROPHECY$103
How this compares
$4,416 in reported general payments places this provider in the 75th percentile of 74 podiatrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 73 | $2,600 |
| Ciclopirox | 43 | $998 |
| Cephalexin | 35 | $187 |
| Clindamycin Hcl | 17 | $146 |
| Oxycodone Hcl | 14 | $71 |
| Meloxicam | 17 | $70 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Portland
- Melinda NicholesPortland$15K
- Lyndon JohansenPortland$6K
- Magnus SchlyerPortland$5K
- Matthew ShookPortland$5K
- Caitlyn McManusPortland$4K
- Meghan TeaguePortland$3K
- Christopher SeuferlingPortland$2K
- Troy SimmonsPortland$1K
- Marshal KennedyPortland$1K
- Stephen HayesPortland$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.